drugset / Trial / NCT00746681
Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder
RandomizedCrossoverTriple-blindTreatment
Summary
Tolterodine is approved for use in the treatment of overactive bladder (OAB). The study is designed to a investigate whether pregabalin may have efficacy in OAB and whether the efficacy is altered when it is combined with tolterodine.
Timeline
- Start
- 2005-12
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 75 mg | Oral |
| Subject | Pregabalin | Small molecule | 150 mg | Oral |
| Subject | Tolterodine | Small molecule | 2 mg | Oral |
| Subject | Tolterodine | Small molecule | 4 mg | Oral |